To protect our staff and visitors from COVID-19, OPA office staff will work remotely. We’ll continue to be fully operational to serve our members. 

Contact us at 416-441-0788 or 1-877-341-0788 or mail@opatoday.com.

Publications

  • News for the Week of March 17, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA's Pharmacist's Guide to Pandemic Preparedness
    • OPA signage for entrances to pharmacy
    • Updated Guidance for Pharmacies on COVID-19 from the Ministry of Health
    • CPhA: COVID-19 and the responsible allocation of medications to patients
    • Sharing your concerns on personal protective equipment
    • Community pharmacy owners support Ontario patients during COVID-19
    • OPA staff work remotely

    • Methadone, Buprenorphine and the Community
    • FREE Take-Home Naloxone at Community Pharmacies
    • Board Certified Geriatric Pharmacist (BCGP) Preparation Course – Medication Therapy Management for Older Adults

    • Ask the Practice Support Network

    • What you need to know when it comes to your benefits

    • DDD Notice No. 20050 posted March 17, 2020 Prescription Forgery Alert
    • DDD Notice No. 20049 posted March 17, 2020 Prescription Forgery Alert
    • DDD Notice No. 20048 posted March 13, 2020 EO Notice: Monitored Drugs List (MDL)

    • Update on the rifampin drug shortage

  • News for the Week of March 10, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Update on COVID-19
    • Pharmacist Awareness Month at Ontario Schools of Pharmacy
    • OPA Thought Leadership Launching During PAM
    • University of Toronto Initiates "I’m Pharmacy” Campaign
    • ICYMI: OPA Celebrates International Women's Day with Launch of Women of Pharmacy Conference Event
    • Board of the Canadian Foundation for Pharmacy Announces New Grant
    • Lung Health Foundation Needs Assessment Survey
    • Humber College Pharmacy Advisory Committee

    • Certified Diabetes Educator (CDE) Preparation Course
    • Identifying Drug Interactions
    • Managing Your Pharmacy: The Business Essentials

    • Ask the Customer Experience and Administration Team

    • Disability Insurance – Q & A

    • DDD Notice No. 20045 Posted March 10, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification

    • Drug Shortage / Supply Health System Alert: Kidrolase

  • News for the Week of March 3, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Uniting as a Profession to Respond to the Needs of Patients During COVID-19
    • Ontario Protecting Children and Youth from Dangers of Vaping
    • Green Shield Canada Brand-Drug Loyalty Card Policy
    • UofT Leslie Dan Faculty of Pharmacy Takes Back the OPA Cup!
    • ICYMI: It's Pharmacist Awareness Month!
    • Complete the Survey on Opioid Use in Cancer-related Pain

    • Opioid Addictions and Substitution Therapy FREE Live Webinar Series - March 11, 2020
    • Certified Diabetes Educator (CDE) Preparation Course *2020 Update*
    • Implementing Smoking Cessation Services in the Pharmacy *2020 Update*

    • Ask the Practice Support Network
    • Nominate a Colleague for an OPA Award!

    • Did You Know Cancer Is the Leading Cause of Death in Canada?

    • DDD Notice No. 20040 posted March 2, 2020 Prescription Forgery Alert
    • DDD Notice No. 20039 posted March 2, 2020 Prescription Forgery Alert
    • DDD Notice No. 20038 posted March 2, 2020 EO Notice: Reconciliation Adjustment Percentages for 2020/21 to Improve the Value of Pharmacy Payments

    • Health Product InfoWatch - February 2020
    • Certain Metformin Diabetes Drugs Recalled Due to the Presence of NDMA

  • News for the Week of February 25, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • The Winter 2020 Issue of Ontario Pharmacist Magazine is here!
    • COVID-19 Resources Available on OPA website
    • Last chance: National Pharmacist Survey on Opioid Prescribing and Dispensing Practices
    • Kick-off this year's Pharmacist Awareness Month with the OPA Cup!
    • Reminder: Deadline to Apply to Allied Health Professional Development Fund is March 2, 2020

    • Essential Cannabis Knowledge for Pharmacists Certificate Program
    • How-To: Ontario’s Pharmaceutical Opinion Program
    • Drugs in Chronic Kidney Disease: Implications for Pharmacists

    • Ask the Customer Experience and Administration Team

    • Practising in Ontario and One or Two Other Provinces?

    • DDD Notice No. 20037 posted February 24, 2020 Prescription Forgery Alert
    • DDD Notice No. 20036 posted February 21, 2020 Prescription Forgery Alert
    • DDD Notice No. 20035 posted February 20, 2020 ODB Formulary – Edition No. 43, Summary of Changes – February 2020
    • DDD Notice No. 20034 posted February 19, 2020 Prescription Forgery Alert
    • DDD Notice No. 20033 posted February 19, 2020 Prescription Forgery Alert
    • DDD Notice No. 20032 posted February 19, 2020 Prescription Forgery Alert

  • News for the Week of February 18, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Consultation Submission on Proposed Changes to OCP Council Governance and Fees
    • ICYMI: COVID-19 Guidance Document for Community Pharmacies
    • National Pharmacist Survey on Opioid Prescribing and Dispensing Practices

    • *New* Wearable Technology
    • Paid Consultations - Opportunities and Timesavers
    • Identifying Drug Interactions

    • Ask the Practice Support Network

    • Planning to Work in Another Province?

    • DDD Notice No. 20029 posted February 12, 2020 Elimination of Red and White Health Card - Posters for Display

  • News for the Week of February 11, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: OPA's Pre-budget Consultation Submission
    • FIP Guidance Resources for Managing Coronavirus in Pharmacy
    • New Awards to Celebrate Leslie Dan Faculty of Pharmacy Alumni
    • University of Waterloo Survey on Readiness to Assess and Prescribe for Minor Ailments
    • ICYMI: Elimination of Red and White Health Cards
    • 2nd Coalition of Pharmacists Caring for Aging Canadians (CPCAC) Scientific Meeting

    • *Free* Methadone, Buprenorphine and the Community
    • Rational Prescribing: Re-Thinking Medications
    • *Free* Assessment and Management of Patients with Migraine

    • Ask the Customer Experience Administration Team

    • Planning to Retire or Moving to Part B?

    • DDD Notice No. 20027 posted February 10, 2020 Trillium Drug Program - New Online Application Form and Guide
    • DDD Notice No. 20028 posted February 11, 2020 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Dexamethasone, Ranitidine, Tamoxifen February 7, 2020

    • Apotex Inc. Recalls Certain Lots of Diabetes Medication APO-Metformin ER (extended release) 500 mg Tablets

  • News For The Week Of February 4, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Novel Coronavirus (2019-nCoV) Resources
    • Deadline to Apply to Allied Health Professional Development Fund is March 2, 2020

    • Opioid Addictions and Substitution Therapy FREE Live Webinar Series
    • Essential Cannabis Knowledge for Pharmacists Certificate Program
    • Applying NAPRA’s Non-Sterile Compounding Standards into Practice

    • Ask the Practice Support Network

    • Store Owners, Did You Know?

    • DDD Notice No. 20015 Posted February 3, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification
    • DDD Notice No. 20016 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20017 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20018 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20019 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20020 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20021 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20022 posted February 4, 2020 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Effient (Prasugrel)

    • Health Product InfoWatch - January 2020

  • News for the Week of January 28, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Ministry of Health Emergency Operations Centre Provides More Resources for Novel Coronavirus (2019-nCoV)
    • Pillar of Pharmacy Award Nominations

    • Certified Diabetes Educator (CDE) Preparation Course
    • Essential Cannabis Knowledge for Pharmacists Certificate Program
    • Methadone, Buprenorphine and the Community

    • Ask the Customer Experience Administration Team

    • Shopping for Auto Insurance?
    • Last Chance to Avoid an Interruption in Your Professional Liability Insurance

    • ODB Formulary – Edition No. 43, Summary of Changes – January 2020

  • News for the Week of January 21, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Last Chance to Have Your Say on Pre-budget Consultations - Complete Our Survey
    • University of Toronto: Class of 2023 White Coat Ceremony
    • Fluwatch - Register to Monitor Flu Activity
    • Clinical Guidelines on Substance Use Disorders in Older Adults from the Canadian Coalition for Seniors' Mental Health
    • Resources from the Ontario Caregiver Organization

    • Methadone, Buprenorphine and the Community
    • Pharmacist Health Coaching – Cardiovascular Program Training Course
    • FAQs and a New Drugs Update on Contraception and Abortion Care

    • Ask the Practice Support Network
    • Looking for Things to Do With the Kids?

    • OPA Pharmacy (Store) Insurance

    • DDD Notice No. 20009 Posted January 16, 2020 Prescription Forgery Alert
    • DDD Notice No. 20010 Posted January 20, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
    • DDD Notice No. 20011 Posted January 21, 2020 Prescription Forgery Alert
    • DDD Notice No. 20012 Posted January 21, 2020 Prescription Forgery Alert

    • Pharmascience Inc. recalls one lot of prescription antifungal drug PMS-Nystatin Oral Suspension: Product may pose a choking risk

Back to top